Microbot Medical Inc. (MBOT) — 10-Q Filings
All 10-Q filings from Microbot Medical Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Microbot Medical's Losses Widen Amidst Significant Capital Influx
— Nov 12, 2025 Risk: high
Microbot Medical Inc. (MBOT) reported a net loss of $3.577 million for the three months ended September 30, 2025, an increase from $3.215 million in the same pe -
Microbot Medical Narrows Q2 Loss Amidst Continued R&D Investment
— Aug 12, 2025 Risk: high
Microbot Medical Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company remains in th -
Microbot Medical Inc. Files Q1 2025 10-Q
— May 14, 2025 Risk: low
Microbot Medical Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE, is based in -
Microbot Medical Inc. Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
Microbot Medical Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qu -
Microbot Medical Inc. Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Microbot Medical Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial position and operational updates. Specific -
Microbot Medical Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
Microbot Medical Inc. (MBOT) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Microbot Medical Inc. filed its 10-Q report for the quarterly period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX